Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Cristi Marin"'
Autor:
Matthieu Delaye, Sabrina Ibadioune, Catherine Julié, Cristi Marin, Frédérique Peschaud, Renato Lupinacci, Sophie Vacher, Ladidi Ahmanache, Samantha Antonio, Anne Schnitzler, Bruno Buecher, Pascale Mariani, Yves Allory, Olfa T. Grati, Jean F. Emile, Cindy Neuzillet, Ivan Bièche
Publikováno v:
European Journal of Cancer. 170:85-90
Gene fusions provide access to new therapeutic opportunities for patients treated for a colorectal cancer (CRC). However, they do not excess 1% of patients. A better identification of patients in whom gene fusions are highly prevalent is a major issu
Publikováno v:
The Annals of “Dunarea de Jos“ University of Galati. Fascicle III, Electrotechnics, Electronics, Automatic Control, Informatics. 44:29-34
The paper is dealing with a comparative analysis of active parallel power filters behaviour (APPF) for different control strategies implemented to the prototypes achieved in the project CRESC-INTEL. The analysis has been made based on results obtaine
Autor:
Janick Selves, Jean-François Emile, Marie Laure Raffin-Sanson, Benoǐt Terris, Chiara Villa, Nicolas Girard, Jérôme Cros, Catherine Julie, Jean François Fléjou, Zofia Hélias-Rodzewicz, Jean Michel Coindre, Christine Lagorce-Pages, Anne Sophie de Lajarte-Thirouard, Nathalie Guedj, Florence Renaud, Dominique Cazals-Hatem, Simon Martin de Beauce, Cristi Marin, Henri Jean Garchon
Publikováno v:
Genes, Chromosomes and Cancer
Genes, Chromosomes and Cancer, Wiley, 2021, 60 (11), pp.723-732. ⟨10.1002/gcc.22981⟩
Genes, Chromosomes & Cancer
Genes, Chromosomes & Cancer, 2021, 60 (11), pp.723-732. ⟨10.1002/gcc.22981⟩
Genes, Chromosomes and Cancer, Wiley, 2021, 60 (11), pp.723-732. ⟨10.1002/gcc.22981⟩
Genes, Chromosomes & Cancer
Genes, Chromosomes & Cancer, 2021, 60 (11), pp.723-732. ⟨10.1002/gcc.22981⟩
International audience; Glomus tumors (GTs) are perivascular tumors mostly occurring in the distal extremities. Rare cases arise in the digestive tract and may be misdiagnosed with neuroendocrine or gastrointestinal stromal tumors. We aimed to specif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3dbe72d7e34942aae589121a0f893b
https://hal.archives-ouvertes.fr/hal-03434935
https://hal.archives-ouvertes.fr/hal-03434935
Autor:
Laure Cazabat, Marie Laure Raffin-Sanson, Sophia Bakopoulou, Cristi Marin, Mirella Hage, Alexis Guyot, Stephan Gaillard, Capucine de Marcellus
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Annales d'Endocrinologie. 80:260-261
Annales d'Endocrinologie - In Press. Accepted Manuscript Available online since jeudi 20 juin 2019
Autor:
Zofia Hélias-Rodzewicz, Elisa Funck-Brentano, Nathalie Terrones, Alain Beauchet, Ute Zimmermann, Cristi Marin, Philippe Saiag, Jean-François Emile
Publikováno v:
BMC Dermatology
BMC Dermatology, Vol 17, Iss 1, Pp 1-10 (2017)
BMC Dermatology, Vol 17, Iss 1, Pp 1-10 (2017)
Background Somatic mutations of BRAF or NRAS activating the MAP kinase cell signaling pathway are present in 70% of cutaneous melanomas. The mutant allele frequency of BRAF V600E (M%BRAF) was recently shown to be highly heterogeneous in melanomas. Th
Autor:
Marius Ilie, Jean-François Emile, David Capper, Philippe Saiag, Andreas von Deimling, Cristi Marin, Alain Beauchet, Paul Hofman, Catherine Julié, U. Zimmermann
Publikováno v:
Archives of Pathology & Laboratory Medicine. 138:71-75
Assessment of BRAF p.V600E mutational status has become necessary for treatment of patients with metastatic melanoma. Detection of p.V600E mutation by immunohistochemistry was recently reported in several tumor types.To evaluate the interobserver rep
Autor:
U. Zimmermann, Andreas von Deimling, Frédérique Peschaud, Dominique Pechaud, Zofia Hélias-Rodzewicz, David Capper, Hélène Blons, Nathalie Terrones, Emeline Colomba, Jean-François Côté, Jean-François Emile, Cristi Marin, T. Clerici, Philippe Saiag, Sylvie Surel
Publikováno v:
The Journal of Molecular Diagnostics. 15:94-100
BRAF p.V600 mutation detection recently became necessary to treat metastatic melanoma patients with vemurafenib. This study compares different methods of detection of BRAF mutations. Melanoma samples from 111 patients were analyzed for BRAF mutations
Autor:
T. Clerici, Jean-François Emile, Frédérique Peschaud, Daphne Bosset, Stephanie Moreau, Cristi Marin, Christine Longvert, S. Chagnon, Philippe Saiag, Zofia Hélias-Rodzewicz, Philippe Aegerter, Utte Zimmermann
Publikováno v:
Annals of Surgical Oncology. 19:4314-4321
Purpose BRAFV600 mutations are frequent in melanomas, and BRAFV600-targeted therapy have dramatic, but often transitory, efficacy in stage IV patients. Prognosis of patients with American Joint Committee on Cancer (AJCC) stage III melanoma is heterog
Publikováno v:
Physics in Medicine and Biology
Physics in Medicine and Biology, IOP Publishing, 2009, 54 (17), pp.5287-5299. ⟨10.1088/0031-9155/54/17/014⟩
Physics in Medicine and Biology, IOP Publishing, 2009, 54 (17), pp.5287-5299
Physics in Medicine and Biology, IOP Publishing, 2009, 54 (17), pp.5287-5299. ⟨10.1088/0031-9155/54/17/014⟩
Physics in Medicine and Biology, IOP Publishing, 2009, 54 (17), pp.5287-5299
International audience; The rationale of this work is to point out the relevance of in vivo MR images of mice obtained using a dedicated low-field system. For this purpose a small 0.1 T water-cooled electro-magnet and solenoidal radio frequency (RF)